Literature DB >> 21937274

Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.

Ralph A H Stewart1, Heather Astell, Laura Young, Harvey D White.   

Abstract

There is currently limited evidence on the safety and efficacy of novel oral anticoagulants in patients with mechanical heart valves. This case report describes a patient with a St Jude aortic valve replacement who suffered valve thrombosis and an embolic stroke when anti-coagulated with the direct thrombin inhibitor dabigatran etexilate.
Copyright © 2011 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21937274     DOI： 10.1016/j.hlc.2011.08.014

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN： 1443-9506            Impact factor:   2.975


  8 in total

1.  Thrombosis on a mechanical mitral valve anticoagulated with dabigatran.

Authors:  Stephanie Coulter; Karla Campos
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

2.  Dabigatran for mechanical valves.

Authors:  Patricia A Howard
Journal:  Hosp Pharm       Date:  2014-04

Review 3.  Bioprosthetic heart valves of the future.

Authors:  Rizwan A Manji; Burcin Ekser; Alan H Menkis; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-01-21       Impact factor: 3.907

Review 4.  Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.

Authors:  A Girolami; E Cosi; S Ferrari; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

5.  Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?

Authors:  Vishesh Kumar; Shawn Kelly; Amol Raizada; Jimmy Yee; Amornpol Anuwatworn; Adam Stys; Maria Stys
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

Review 6.  Role of novel anticoagulants for patients with mechanical heart valves.

Authors:  Peter Forsberg; Maria T DeSancho
Journal:  Curr Atheroscler Rep       Date:  2014-11       Impact factor: 5.113

Review 7.  Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.

Authors:  Luigi Di Biase
Journal:  J Am Heart Assoc       Date:  2016-02-18       Impact factor: 5.501

Review 8.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.